These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12730773)

  • 1. Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years.
    Newman ED; Ayoub WT; Starkey RH; Diehl JM; Wood GC
    Osteoporos Int; 2003 Apr; 14(2):146-51. PubMed ID: 12730773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
    Brecht JG; Kruse HP; Felsenberg D; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2003; 23(4):93-105. PubMed ID: 15224498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of treating osteoporosis in a managed health care organization.
    Desai SS; Duncan BS; Sloan AS
    J Manag Care Pharm; 2003; 9(2):142-9. PubMed ID: 14613343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and costs of osteoporosis-associated hip fractures in Austria.
    Koeck CM; Schwappach DL; Niemann FM; Strassmann TJ; Ebner H; Klaushofer K
    Wien Klin Wochenschr; 2001 May; 113(10):371-7. PubMed ID: 11432126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs.
    Sander B; Elliot-Gibson V; Beaton DE; Bogoch ER; Maetzel A
    J Bone Joint Surg Am; 2008 Jun; 90(6):1197-205. PubMed ID: 18519311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct costs of osteoporosis and hip fracture: an analysis for the Mexican healthcare system.
    Clark P; Carlos F; Barrera C; Guzman J; Maetzel A; Lavielle P; Ramirez E; Robinson V; Rodriguez-Cabrera R; Tamayo J; Tugwell P
    Osteoporos Int; 2008 Mar; 19(3):269-76. PubMed ID: 18060586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.
    Majumdar SR; Johnson JA; Lier DA; Russell AS; Hanley DA; Blitz S; Steiner IP; Maksymowych WP; Morrish DW; Holroyd BR; Rowe BH
    Osteoporos Int; 2007 Mar; 18(3):261-70. PubMed ID: 17086470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis.
    Borgström F; Johnell O; Kanis JA; Jönsson B; Rehnberg C
    Osteoporos Int; 2006 Oct; 17(10):1459-71. PubMed ID: 16847588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
    Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
    J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study.
    Chang KP; Center JR; Nguyen TV; Eisman JA
    J Bone Miner Res; 2004 Apr; 19(4):532-6. PubMed ID: 15005838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of fewer hip fractures with risedronate versus alendronate in the first year of treatment: modeled German cost-effectiveness analysis.
    Thompson M; Pasquale M; Grima D; Moehrke W; Kruse HP
    Value Health; 2010; 13(1):46-54. PubMed ID: 19883401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic comparison of diagnostic approaches for evaluating osteoporosis in older women.
    Kraemer DF; Nelson HD; Bauer DC; Helfand M
    Osteoporos Int; 2006 Jan; 17(1):68-76. PubMed ID: 15889313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intervention thresholds for the treatment of osteoporosis: comparison of different approaches to decision-making.
    Epstein RS; Feng W; Hirsch LJ; Kelly M
    Osteoporos Int; 1998; 8 Suppl 1():S22-7. PubMed ID: 9682793
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of the incremental cost and clinical burden of hip fractures in postmenopausal women in the United Kingdom.
    Gutiérrez L; Roskell N; Castellsague J; Beard S; Rycroft C; Abeysinghe S; Shannon P; Robbins S; Gitlin M
    J Med Econ; 2011; 14(1):99-107. PubMed ID: 21222505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making the most of managed care dollars spent for postmenopausal osteoporosis.
    Ettinger B
    Manag Care Interface; 2005 Dec; 18(12):55-9. PubMed ID: 16405226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic aspects of osteoporosis].
    Stĕpán J; Smíd M; Prokes M; Palicka V; Honzáková L; Havelka S; Blahos J; Bayer M
    Cas Lek Cesk; 1998 Nov; 137(23):707-15. PubMed ID: 9990174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effective osteoporosis intervention thresholds for Hong Kong postmenopausal women.
    Kung AW; McGhee SM; Tsang SW; So J; Chau J
    Hong Kong Med J; 2015 Dec; 21 Suppl 6():13-6. PubMed ID: 26645876
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.
    Ray NF; Chan JK; Thamer M; Melton LJ
    J Bone Miner Res; 1997 Jan; 12(1):24-35. PubMed ID: 9240722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.
    Hochberg MC; Thompson DE; Black DM; Quandt SA; Cauley J; Geusens P; Ross PD; Baran D;
    J Bone Miner Res; 2005 Jun; 20(6):971-6. PubMed ID: 15883637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.